Recombinant Rat coronavirus Hemagglutinin-esterase (HE)
Product Specs
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Note: Shipping defaults to blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.
The tag type is determined during production. If a specific tag type is required, please inform us for preferential development.
Target Background
Recombinant Rat coronavirus Hemagglutinin-esterase (HE) is a structural protein forming short surface spikes on the virus. It exhibits receptor-binding and receptor-destroying activities, mediating the de-O-acetylation of N-acetyl-4-O-acetylneuraminic acid, a crucial receptor determinant for erythrocyte and susceptible cell binding. This receptor-destroying activity is essential for viral release, preventing self-aggregation and ensuring efficient cell-to-cell progeny spread. HE may function as a secondary viral attachment protein, complementing the primary spike protein in initiating infection. It is a potential target for both humoral and cellular immune responses.
Q&A
What is the hemagglutinin-esterase (HE) protein in rat coronaviruses?
The hemagglutinin-esterase (HE) protein in rat coronaviruses functions as a secondary spike glycoprotein. Similar to the well-studied murine coronavirus HE, it likely serves as a second receptor-binding protein that enhances viral infection efficiency and promotes viral dissemination . In rat coronaviruses such as SDAV, HE appears to play roles similar to those observed in other group 2 coronaviruses, combining receptor-binding and receptor-destroying enzyme (RDE) activities that mediate reversible virus attachment to sialic acid receptor determinants .
The HE protein has been established as a sialate-O-acetylesterase, with substrate preferences that typically match the sialic acid receptor specificity of the virions. This dual functionality allows HE to potentially assist the spike (S) protein during cell entry processes .
How is HE expression regulated during coronavirus infection?
Studies of murine hepatitis virus (MHV) demonstrate that HE expression is dynamically regulated during infection. In cell culture systems, HE expression can sometimes be detrimental to viral propagation, suggesting complex selective pressures . When recombinant viruses expressing HE are propagated in vivo, maintenance of HE expression varies by tissue environment.
In experiments with recombinant MHV, researchers found that after replication in mouse brains, approximately 97% ± 1.5% of recovered viruses maintained functional HE expression, while this percentage dropped to 87.5% ± 1.5% in viruses recovered from the liver - a statistically significant difference (p < 0.05) . This suggests tissue-specific selection pressures that may influence the maintenance of HE expression during infection.
What structural and functional characteristics define coronavirus HE proteins?
Coronavirus HE proteins combine receptor-binding capability (hemagglutination) with enzymatic activity (esterase). These proteins demonstrate hemagglutinating activity in assays, confirming their role as sialic acid-specific lectins . The enzymatic component functions as a sialate-O-acetylesterase, with specificity that varies between coronavirus strains.
For example, MHV strains S and JHM bind to 5-N-acetyl-4-O-acetylneuraminic acid (Neu4,5Ac₂) receptors and their HE proteins correspondingly exhibit sialate-4-O-acetylesterase activity . In contrast, other group 2 coronaviruses like BCoV, HCoV-OC43, and MHV-DVIM specifically bind to Neu5,9Ac₂ moieties and encode HEs with sialate-9-O-acetylesterase activity . This correlation between receptor binding specificity and enzymatic activity suggests a coordinated evolutionary relationship.
How does HE expression impact coronavirus virulence and pathogenesis?
The impact of HE expression on coronavirus virulence appears to be context-dependent, particularly in relation to the accompanying spike protein. Experimental evidence from recombinant MHV studies demonstrates this relationship clearly:
In survival studies with recombinant viruses, mice infected with JHM-S and HE-expressing viruses showed significantly lower survival rates (0-30%) compared to those infected with viruses expressing JHM-S but lacking HE (70-90% survival) . Statistical analysis confirmed these differences were highly significant (p < 0.0001) .
What is the relationship between HE enzymatic activity and virulence?
Intriguingly, research with recombinant coronaviruses reveals that the structural presence of HE, rather than its enzymatic activity, appears to be the critical factor influencing virulence. Recombinant viruses expressing enzymatically active HE (HE⁺) and those expressing structurally intact but enzymatically inactive HE (HE⁰) demonstrated similar pathogenic properties .
In survival experiments with low-dose intracranial inoculation, both types of viruses caused rapid mortality with similar survival rates, while HE-negative viruses resulted in significantly higher survival rates . This suggests that HE's contribution to virulence may be primarily through its role as a secondary receptor-binding protein rather than through its esterase activity.
| Recombinant Virus Type | Median Survival Time | Survival Rate | Clinical Signs |
|---|---|---|---|
| rMHV-JHMS-HE⁺ | 8-9 days | 0-30% | Early onset (day 4-5) |
| rMHV-JHMS-HE⁰ | 8-9 days | 0-30% | Early onset (day 4-5) |
| rMHV-JHMS-HE⁻ | Significantly longer | 70-90% | Limited, later onset |
What approaches are effective for generating recombinant coronaviruses with modified HE expression?
Researchers have successfully developed several strategies for creating isogenic recombinant coronaviruses that differ only in HE expression. Based on the experimental approaches described in the literature, an effective methodology includes:
-
Creating three types of constructs:
-
Generating independent isolates of each recombinant type to ensure that spontaneous mutations elsewhere in the genome do not confound results .
-
Verifying HE expression and incorporation into virions through techniques such as immunopurification of metabolically labeled virions .
-
Confirming enzymatic activity (or lack thereof) through esterase staining of viral plaques .
This systematic approach allows for rigorous examination of HE's role by distinguishing between effects of protein structure versus enzymatic activity.
How can researchers quantify viral spread mediated by HE in vivo?
Effective assessment of HE-mediated viral spread requires a multifaceted approach combining quantitative and qualitative methods:
-
Viral titers in target organs: While useful, titers alone may not accurately reflect neurovirulence. Studies have shown that viruses with different HE status can replicate to similar titers despite significant differences in pathogenicity .
-
Immunohistochemical analysis: Examination of tissue sections provides critical insight into viral antigen distribution. This approach revealed that HE-expressing recombinant viruses showed extensive viral antigen spread throughout brain regions, while HE-deficient viruses showed limited antigen-positive cells confined to small foci, despite similar viral titers .
-
Plaque purification from tissue homogenates: Direct isolation of viruses from infected tissues, followed by characterization of HE expression, allows assessment of selection pressures on HE during in vivo replication .
When combined, these approaches provide comprehensive evaluation of how HE influences viral dissemination in different tissues.
What molecular mechanisms underlie HE-mediated enhancement of viral spread?
The molecular basis for HE-mediated enhancement of viral spread appears to involve several potential mechanisms:
-
Dual receptor engagement: HE likely serves as a secondary receptor-binding protein that complements the primary attachment mediated by the S protein. This provides additional binding options for the virus, potentially increasing infection efficiency .
-
Tissue-specific receptor interaction: HE proteins bind to sialic acid moieties with specificities that match the receptor preferences of the virion. For instance, MHV strains S and JHM bind to 5-N-acetyl-4-O-acetylneuraminic acid (Neu4,5Ac₂) receptors, and their HE proteins show corresponding sialate-4-O-acetylesterase activity .
-
Synergistic interaction with spike protein: The dramatic enhancement of neurovirulence and viral spread observed when HE is expressed alongside the JHM spike (but not the A59 spike) suggests a specific synergistic interaction between these proteins .
-
Receptor-destroying enzyme activity: While not directly linked to increased virulence in experimental models, the esterase activity may facilitate viral release and spread in natural infections by preventing virion aggregation on cell surfaces .
How does HE expression influence coronavirus tissue tropism?
The relationship between HE expression and tissue tropism appears complex. While the spike protein remains the primary determinant of organ and cell tropism, HE can modify the efficiency of infection within permissive tissues:
-
Brain infection: In recombinant MHV studies, HE expression dramatically enhanced viral spread throughout brain regions when paired with the JHM spike protein, but had minimal impact when paired with the A59 spike protein .
-
Liver tropism: HE expression did not significantly alter hepatotropism in either A59 or JHM spike-containing recombinant viruses .
-
Retention of HE expression: The higher retention rate of functional HE in viruses recovered from brain tissue (97%) compared to liver tissue (87.5%) suggests potential tissue-specific advantages for HE expression .
These observations suggest that while S primarily determines which tissues can be infected, HE may enhance infection efficiency and spread in specific tissue environments, particularly the central nervous system.
What experimental models are most appropriate for studying rat coronavirus HE?
Based on the research approaches used for studying related coronavirus HEs, optimal experimental models for rat coronavirus HE would include:
-
In vitro systems:
-
In vivo models:
-
Molecular tools:
These approaches would enable comprehensive investigation of rat coronavirus HE function while accounting for the unique characteristics of SDAV infection.
What are the key unanswered questions about rat coronavirus HE?
Several important questions remain unresolved regarding rat coronavirus HE, representing valuable opportunities for future research:
-
The precise sialic acid specificity of rat coronavirus HE and how it compares to other rodent coronavirus HEs
-
Whether SDAV HE shows the same pattern of differential impact on virulence when combined with different spike proteins
-
The evolutionary relationships between rat coronavirus HE and HE proteins from other species
-
The role of HE in natural SDAV infections of rat salivary and lacrimal glands
-
Whether HE serves as a virulence factor in rat-to-rat transmission of SDAV
How might research on rat coronavirus HE inform broader coronavirus biology?
Investigations of rat coronavirus HE have significant potential to advance our understanding of coronavirus biology in several ways:
-
As a model for accessory protein function: HE represents an accessory protein that enhances but is not essential for viral replication, making it an excellent model for understanding how such proteins contribute to viral fitness .
-
Comparative virology: Studying similarities and differences between rat coronavirus HE and other coronavirus HEs can illuminate evolutionary processes in coronavirus adaptation .
-
Host-pathogen interactions: Understanding how HE interacts with rat-specific receptors could provide insights into species barriers and zoonotic potential of coronaviruses.
-
Potential therapeutic targets: The receptor-binding and enzymatic functions of HE represent potential targets for antiviral strategies against coronaviruses.
